Zealand Pharma A/S (ZEAL): IPOs News

ZEAL – Prices 4.375 mln share IPO (upsized from 3.9 mln prior) at $17.87 per ADS, below the expected price of $19.25.

Key Facts Surrounding This News Item

  • ZEAL had returned 0.00% year-to-date leading up to today’s news, versus a +11.64% return from the benchmark S&P 500 during the same period.

More Info About Zealand Pharma A/S (ZEAL)

Zealand Pharma A/S, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark. The company was founded in 1997 and is based in Copenhagen, Denmark. View our full ZEAL ticker page with ratings, news, and more.

ZEAL at a Glance

ZEAL Current POWR Rating™
Overall POWR Rating™
ZEAL Current Price $13.69 2.21%
More ZEAL Ratings, Data, and News

ZEAL Price Reaction

The day of this event (Aug. 9, 2017)
ZEAL Closing Price$17.82 N/A%
ZEAL Volume1,715,000
N/A% from avg
Leading up to this event
ZEAL 1-mo returnN/A%
After this event
ZEAL 1-day returnN/A%
ZEAL 3-day returnN/A%
ZEAL 5-day returnN/A%

ZEAL Price Chart

More Zealand Pharma A/S (ZEAL) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ZEAL News
Page generated in 0.7911 seconds.